Brief: Guerbet Says FDA Approves Labeling Update For Guerbet's Elucirem Injection

Guerbet SA

20/02/2026 16:39

Feb 20 (Reuters) - Guerbet SA GRBT.PA:

NEW INDICATION IN PEDIATRIC PATIENTS, INCLUDING TERM NEONATES FOR GUERBET'S HALF-DOSE GBCA, ELUCIREM™ (GADOPICLENOL) INJECTION

GUERBET SA - FDA APPROVES LABELING UPDATE FOR GUERBET'S ELUCIREM INJECTION

GUERBET SA - NEW INDICATION INCLUDES APPROVAL FOR PEDIATRIC PATIENTS AGED 0-2 YEARS FOR ELUCIREM

Source text: ID:nPn7Chz2va

Further company coverage: GRBT.PA

 ((((Reuters.Briefs@thomsonreuters.com));))